MIT neuroscientists have discovered that the adult brain contains millions of "silent synapses"—immature connections between neurons that remain inactive until they're recruited to help form new memories.
Nov 30, 2022
0
105
A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a new study published in The Lancet Infectious ...
Nov 29, 2022
0
100
University of Saskatchewan (USask) researchers have developed a new method of killing brain cancer cells while preserving the delicate tissue around it. The technique also has a remarkable side-benefit: making chemotherapy ...
Nov 25, 2022
0
1352
Not only is depression a debilitating disease, but it is also widespread. Approximately 20 million adult Americans experience at least one episode of depression per year.
Nov 17, 2022
0
14
The head of the World Health Organization said Wednesday that he expects the first doses of Ebola vaccine targeting the strain behind an outbreak in Uganda to arrive in the country next week.
Nov 16, 2022
0
6
A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug's "high." The breakthrough ...
Nov 14, 2022
1
96
Multiple sclerosis (MS) is an autoimmune disease affecting the brain and spinal cord. In MS, the activated immune cells attack myelin, a protective layer surrounding nerve cells, which disrupts the transmission of nerve impulses ...
Nov 10, 2022
0
5
Q: My toddler often puts small objects in her mouth. How can I keep her safe with all the button batteries in our house?
Nov 9, 2022
0
3
As the days get shorter and the weather colder in the northern hemisphere, health officials have warned of a perfect storm of infectious respiratory diseases over the winter months.
Nov 9, 2022
0
19
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led ...
Nov 8, 2022
0
18
